These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1985870)

  • 1. Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells.
    Lu L; Shen RN; Lin ZH; Aukerman SL; Ralph P; Broxmeyer HE
    Int J Cancer; 1991 Jan; 47(1):143-7. PubMed ID: 1985870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of recombinant human interleukin 6, alone or in combination with local irradiation, on tumor growth in Lewis lung carcinoma-bearing mice.
    Lu L; Shen RN; Broxmeyer HE
    Int J Cell Cloning; 1991 Sep; 9(5):511-20. PubMed ID: 1955739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
    Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human macrophage-colony stimulating factor on marrow, splenic, and peripheral hematopoietic progenitor cells in mice.
    Yamauchi T; Yada K; Umemura A; Asakura E; Hanamura T; Tanabe T
    J Leukoc Biol; 1996 Feb; 59(2):296-301. PubMed ID: 8604003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells.
    Shen RN; Lu L; Wu B; Shidnia H; Hornback NB; Broxmeyer HE
    Cancer Res; 1990 Aug; 50(16):5027-30. PubMed ID: 2379168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice.
    Morita T; Ikeda K; Douzono M; Yamada M; Kimura F; Kawakami K; Sasaki K; Motoyoshi K; Takahara J; Irino S
    Blood; 1996 Aug; 88(3):955-61. PubMed ID: 8704254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
    Young MR; Aquino S; Young ME
    J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME; Wepsic HT
    Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors.
    Young MR; Young ME; Wright MA
    Exp Hematol; 1990 Aug; 18(7):806-11. PubMed ID: 2143138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice.
    Bungart B; Loeffler M; Goris H; Dontje B; Diehl V; Nijhof W
    Br J Haematol; 1990 Oct; 76(2):174-9. PubMed ID: 1709805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF.
    Oghiso Y; Yamada Y; Ando K; Ishihara H; Shibata Y
    J Leukoc Biol; 1993 Jan; 53(1):86-92. PubMed ID: 7678847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR; Wright MA
    Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect in vivo of multiple injections of purified murine and recombinant human macrophage colony-stimulating factor to mice.
    Chikkappa G; Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Greenberg ML; Waheed A; Shadduck RK
    Cancer Res; 1989 Jul; 49(13):3558-61. PubMed ID: 2659162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
    Broxmeyer HE; Williams DE; Cooper S; Hangoc G; Ralph P
    J Cell Biochem; 1988 Oct; 38(2):127-36. PubMed ID: 2464604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma.
    Walsh P; Dorner A; Duke RC; Su LJ; Glode LM
    J Natl Cancer Inst; 1995 Jun; 87(11):809-16. PubMed ID: 7791230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation.
    Watanabe T; Kelsey LS; Yan Y; Brown GS; Jackson JD; Ewel C; Talmadge JE
    Br J Haematol; 1996 Sep; 94(4):619-27. PubMed ID: 8826883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.